Skip to main content

Table 2 Results of follow-up and clinical visits 1 = median follow-up time in years, starting from the introduction of the new follow-up scheme; 2 = number of outpatient clinical visits to the surgeon for follow-up of CRC

From: Evaluation of the use of decision-support software in carcino-embryonic antigen (CEA)-based follow-up of patients with colorectal cancer

 

CEAwatch

Usual Care

P

Median study follow-up time1 (range)

0.96 ( 0.10-1.39 )

1.34 (0.10-1.66)

0.01

Median total follow-up time (range)

2.66 (0.2-10.8 )

3.21 (0.10-6.05)

0.35

Outpatient clinics2

0 ( 0-7 )

3 ( 0-10 )

<0.001

Metastases found in follow-up (%)

16 (9)

8 (13)

0.06

Curative metastasectomy

7/16

1/8

0.13